Histocompatibility antigens in chronic liver disease.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 299725)

Published in Gastroenterology on January 01, 1977

Authors

B B Scott, S M Rajah, M S Losowsky

Articles by these authors

Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47

Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut (2000) 3.22

Oesophageal achalasia in adolescent women mistaken for anorexia nervosa. BMJ (1992) 2.78

Painful rib syndrome--a review of 76 cases. Gut (1993) 2.53

Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther (2006) 2.49

Patchiness and duodenal-jejunal variation of the mucosal abnormality in coeliac disease and dermatitis herpetiformis. Gut (1976) 2.40

Prospective study of thrombophlebitis and "pseudothrombophlebitis". Lancet (1980) 2.22

Stigmata of recent haemorrhage in diagnosis and prognosis of upper gastrointestinal bleeding. Br Med J (1978) 2.17

Dietary treatment of active Crohn's disease. BMJ (1997) 2.05

Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther (2010) 2.02

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94

Immune response to Campylobacter pyloridis. Lancet (1985) 1.86

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut (2000) 1.81

The effect of dipyridamole on platelet function: correlation with blood levels in man. Br J Clin Pharmacol (1977) 1.80

Review article: monitoring for drug side-effects in inflammatory bowel disease. Aliment Pharmacol Ther (2002) 1.79

Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70

Rectal mucosal plasma cells in inflammatory bowel disease. Gut (1983) 1.56

T-lymphocyte populations in normal and coeliac small intestinal mucosa defined by monoclonal antibodies. Gut (1986) 1.56

Coeliac disease: a cause of various associated diseases? Lancet (1975) 1.53

Vitamin status in treated patients with cystic fibrosis. Arch Dis Child (1981) 1.45

Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation. Br J Surg (1978) 1.42

Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change. Gastroenterology (1981) 1.41

Radio-opaque pellets as faecal markers for faecal fat estimation in malabsorption. Gut (1979) 1.40

The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes. Clin Exp Immunol (1985) 1.39

Cell-mediated immunity to gluten fraction III in adult coeliac disease. Gut (1978) 1.39

Peroral small-intestinal biopsy: experience with the hydraulic multiple biopsy instrument in routine clinical practice. Gut (1976) 1.37

Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci (Lond) (1989) 1.36

Iron deficiency anaemia--how far to investigate? Gut (1993) 1.34

Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child (1984) 1.34

Splenic size and function in adult coeliac disease. Br J Radiol (1980) 1.29

Super-efficient starch absorption. A risk factor for colonic neoplasia? Dig Dis Sci (1987) 1.28

Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease. Gut (1983) 1.28

Transgenic songbirds offer an opportunity to develop a genetic model for vocal learning. Proc Natl Acad Sci U S A (2009) 1.28

Human factor XIII: fibrin-stabilizing factor. Prog Hemost Thromb (1980) 1.27

Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro. Clin Exp Immunol (1986) 1.27

Salmonella gastroenteritis--another cause of erythema nodosum. Br J Dermatol (1980) 1.26

Why are Alzheimer patients thin? Age Ageing (1988) 1.26

Steroid-responsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child (1981) 1.24

Chemical faecal fat using single stools. Scand J Gastroenterol (1971) 1.23

Improved diagnostic accuracy of a modified oral pancreatic function test. Scand J Gastroenterol (1979) 1.23

What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol (1988) 1.23

Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease. Clin Exp Immunol (1991) 1.22

Does super efficient starch absorption promote diverticular disease? Br Med J (Clin Res Ed) (1986) 1.21

Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol (1997) 1.21

Gastro-oesophageal candidiasis. Gut (1982) 1.20

Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Dig Dis Sci (1991) 1.20

Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins. Scand J Gastroenterol (1984) 1.20

Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J Clin Pathol (1986) 1.19

Acute arthritis associated with Clostridium difficile colitis. Br Med J (Clin Res Ed) (1981) 1.18

Clinical relevance of an unfused pancreatic duct system. Gut (1979) 1.17

Defining duodenitis: quantitative histological study of mucosal responses and their correlations. J Clin Pathol (1985) 1.17

Evidence of vitamin E deficiency in patients with malabsorption or alcoholism and the effects of therapy. Gut (1967) 1.17

Small intestinal plasma cells in coeliac disease. Gut (1984) 1.16

Opioid peptides and primary biliary cirrhosis. BMJ (1988) 1.16

ELISA for measurement of secretory IgA distinct from monomeric IgA. J Immunol Methods (1987) 1.16

Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies. Clin Pharmacol Ther (2009) 1.14

Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis. Gut (1973) 1.14

Endoscopic small intestinal biopsy. Gastrointest Endosc (1981) 1.13

Intake and absorption of tocopherol. Ann N Y Acad Sci (1972) 1.12

Hyposplenism, adult coeliac disease, and autoimmunity. Gut (1981) 1.11

Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther (1996) 1.11

Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies. Infect Immun (1987) 1.11

Endomysial antibody in the diagnosis and management of coeliac disease. Postgrad Med J (2000) 1.11

The distribution of erythroblast iron in sideroblastic anaemias. Br J Haematol (1966) 1.11

Cell-mediated immunity to gluten within the small intestinal mucosa in coeliac disease. Gut (1982) 1.09

Consequences of impaired splenic function. Clin Sci (Lond) (1979) 1.08

Campylobacter pylori, duodenal ulcer disease, and gastrin. BMJ (1989) 1.06

Identification and characterization of the human hepatic androgen receptor. Clin Endocrinol (Oxf) (1985) 1.06

Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock. Circ Shock (1989) 1.05

Vitamin E levels after gastric surgery. Gut (1966) 1.05

Colonic mucosal T lymphocytes in ulcerative colitis: expression of CD7 antigen in relation to MHC class II (HLA-D) antigens. Dig Dis Sci (1989) 1.05

Routine colonoscopy service. Arch Dis Child (1984) 1.03

The gastrointestinal absorption of paracetamol in the rat. J Pharm Pharmacol (1979) 1.03

Preliminary evaluation of a single-day tubeless test of pancreatic function. Br Med J (Clin Res Ed) (1981) 1.03

The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time. Br J Clin Pharmacol (1979) 1.03

The bones in chronic liver disease. Scand J Gastroenterol (1967) 1.02

Liver disease and malabsorption. Gastroenterology (1969) 1.01

HLA-B8 and cell-mediated immunity to gluten. Gut (1981) 1.01

Effect of alpha-tocopherol administration on red cell survival in vitamin E-deficient human subjects. Am J Clin Nutr (1971) 1.01

Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to gram-negative endotoxin core glycolipids. Vox Sang (1987) 1.01

Expression of the common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol (1985) 1.01

Lipid metabolism in acute and chronic renal failure. J Lab Clin Med (1968) 1.00

Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides? Gut (1988) 1.00

The clinical course of viral hepatitis. Clin Gastroenterol (1980) 1.00

Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial. J Thorac Cardiovasc Surg (1985) 1.00

Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis. J Clin Pathol (1982) 1.00

Coeliac disease and dermatitis herpetiformis: further studies of their relationship. Gut (1976) 0.99

A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q J Med (1984) 0.98

Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis. J Clin Pathol (1992) 0.98

Primary biliary cirrhosis and chronic active hepatitis: an examination of clinical, biochemical, and histopathological features in differential diagnosis. J Clin Pathol (1985) 0.97

Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease. Clin Exp Immunol (1987) 0.97

Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol (1991) 0.97

Factor XIII. Br J Haematol (1977) 0.97

To perform or not to perform liver biopsy: an alternative view. Gut (2003) 0.97